针对Candida albicans的抗真菌类的结构优化
1Middle Tennessee State University, Department of Chemistry, 1301 E. Main St., Murfreesboro, Tennessee 37132, United States.
ACS medicinal chemistry letters
|July 16, 2025
概括
研究人员优化了抗真菌类药物,以对抗耐药性真菌感染. 修改后的peptoid 911-M12对抗耐药的Candida物种和具有低毒性的Cryptococcus neoformans具有强有力的活性.
科学领域:
- 药用化学 医学化学
- 发现抗微生物药物 发现抗微生物药物
- 分子生物学分子生物学
背景情况:
- 真菌感染是一个重大的全球健康挑战,因抗真菌耐药性增加和治疗选择有限而加剧.
- 类药物正在成为一种有前途的抗真菌剂,因为它们的稳定性和生物可用性比传统药物优越.
研究的目的:
- 使用结构-活性关系 (SAR) 方法优化抗真菌RMG9-11的方法.
- 为了提高抗真菌功效和选择性,同时最大限度地减少细胞毒性.
主要方法:
- 通过四个代循环的结构修改合成50个peptoid衍生物.
- 对关键真菌病原体的抗真菌活性的评估,包括多药耐药菌株.
- 对细胞毒性的评估以确定选择性比率.
主要成果:
- 几种合成衍生品表现出改善的抗真菌活性和选择性.
- 五种化合物显示出对白虫的有效性有所提高.
- 这种化合物911-M12对抗多药耐药性C的强有力的活性. 阿尔比卡人,C.阿尔比卡人 奥里斯,以及C. 新型药物 (MICs 3.136.25 μg/mL) 具有较低的细胞毒性 (TD50 = 145 μg/mL).
结论:
- 代SAR研究对于开发有效的抗真菌类药物至关重要.
- 优化的peptoid 911-M12是治疗耐药真菌感染的有希望的候选者.
相关概念视频
Candidiasis
Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...


